These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15507756)

  • 1. The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodies.
    Jayne D
    Jpn J Infect Dis; 2004 Oct; 57(5):S16-7. PubMed ID: 15507756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of myeloperoxidase in vasculitis development.
    Suzuki K; Okazaki T
    Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concealed hypothyroidism in patients with myeloperoxidase antineutrophili cytoplasmic autoantibodies- (MPO-ANCA) positive renal disease.
    Tanaka A; Maeda K; Sawai K; Okuda J; Sugawara A; Kuwahara T
    Clin Nephrol; 1999 Aug; 52(2):91-5. PubMed ID: 10480219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of autoantibodies to myeloperoxidase on neutrophil function and intracellular signaling.
    Williams J; Hewins P; Savage C
    Jpn J Infect Dis; 2004 Oct; 57(5):S5-6. PubMed ID: 15507770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic granulomatous necrotizing vasculitis in a MPO-ANCA-positive patient.
    Kurata A; Nishimura Y; Yamato T; Arimura Y; Yamada A; Sakamoto A; Fujioka Y
    Pathol Int; 2004 Aug; 54(8):636-40. PubMed ID: 15260856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride.
    Esnault VL; Mathieson PW; Thiru S; Oliveira DB; Martin-Lockwood C
    Lab Invest; 1992 Jul; 67(1):114-20. PubMed ID: 1320710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut.
    Heeringa P; Foucher P; Klok PA; Huitema MG; Tervaert JW; Weening JJ; Kallenberg CG
    Am J Pathol; 1997 Jul; 151(1):131-40. PubMed ID: 9212739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
    Schmitt WH
    Jpn J Infect Dis; 2004 Oct; 57(5):S7-8. PubMed ID: 15507771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
    Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
    J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.
    Nagai M; Hirayama K; Ebihara I; Shimohata H; Kobayashi M; Koyama A
    Nephron Clin Pract; 2011; 118(4):c339-45. PubMed ID: 21293157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
    Pollock W; Trevisin M; Savige J;
    J Immunol Methods; 2008 Dec; 339(2):141-5. PubMed ID: 18823991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.